Cypheme launches an AI-based counterfeit detector in OpenAI’s GPTStore, enabling consumers to identify fake health products using a smartphone camera
According to Interpol, more than one million people die each year from counterfeit drugs – up to 30 percent of drugs sold worldwide are counterfeit, causing health problems and even death for millions of people – highlighting one of the fastest-growing and most lucrative income sources for global organized crime networks.
The International Crime Police Organisation also found that more than 200,000 people die each year from counterfeit anti-allergy drugs alone. Some of the most common counterfeit drugs are antibiotics, HIV/AIDS and cancer medication, antidepressants, drugs to treat erectile dysfunction, weight-loss supplements, and anti-malaria medication.
Additionally, a 2011 survey by the World Health Organization (WHO) revealed that 64% of antimalarial drugs were counterfeit, with over 70% of drugs consumed in Nigeria being counterfeit. These counterfeit medicines often bear Nigerian registration numbers and false manufacturing dates, while also convincingly mimicking the logos of trusted brands.
Cypheme‘s AI-based counterfeit detector in OpenAI’s GPTStore enables consumers to verify the authenticity of health products using just a standard smartphone camera. Cypheme’s AI technology, known as ‘Deep Tracing,’ distinguishes between genuine and counterfeit products by analyzing photos of the product packaging.
Another unique aspect of this AI: it is exclusively trained using images of authentic packages, as opposed to training with both real and known counterfeit packaging images, which would be a much less challenging task for an image-processing AI. It can detect counterfeit medicine by spotting anomalies in the packaging.
In the case of Lonart, one of the most used anti-malaria medicines in Nigeria, with a lot of fakes, Cypheme’s AI anti-counterfeit technology focuses on tracing accuracy, with a model that can distinguish between fake and genuine products with an impressive accuracy rate of 99.54%.
“We are confident that this new solution will significantly disrupt the global counterfeit medicine trade, empowering consumers to identify counterfeit products. Cypheme’s groundbreaking detector integrated into OpenAI’s GPTStore addresses the critical issue of consumer vulnerability to counterfeit medicines.” Hugo García-Cotte, CEO of Cypheme.
According to the European Commission, Counterfeiting is a crime, involving the manufacturing or distribution of goods under someone else’s name, and without their permission. According to the International Chamber of Commerce, the total value of counterfeit and pirated goods globally is around €1.77 trillion. Each year EU companies lose €83 billion in sales due to counterfeited products.
Cypheme previously received support from the European Union, as one of the top AI companies in Europe selected for the Horizon 2020 program, for their Noise Print. This technology already used AI analysis for detecting fake medicine and medical equipment, but this time, by analyzing the microstructure of a special certificate added to the packaging. The Noise print technology was already trusted to protect more than €140 million worth of products worldwide in 2022.
About Cypheme
Provides brands, manufacturers, and governments with algorithm-powered labels that are supported by robust Artificial Intelligence (AI) which verifies a product’s authenticity. This is made possible because of the unique fingerprint labels that cannot be copied or reproduced.
The company is the only anti-counterfeit solution that has been ISO 12931 Qualified. It has won numerous awards and accolades such as the Artificial Intelligence Awards 2020, the European Commission Horizon 2020, and the APAC Insider Business Award 2020 among many others.